[1]周 鹏,孙妲男,李 勇,等.解毒活血汤对慢性肾脏病大鼠肾脏FGF23、Klotho表达的影响[J].陕西中医,2024,(1):13-16,22.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.003]
　ZHOU Peng,SUN Danan,LI Yong,et al.Effects of Jiedu Huoxue decoction on the expression of FGF23 and Klotho in the kidneys of rats with chronic kidney disease[J].,2024,(1):13-16,22.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.003]
点击复制

解毒活血汤对慢性肾脏病大鼠肾脏FGF23、Klotho表达的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
13-16,22
栏目:
基础研究
出版日期:
2024-01-05

文章信息/Info

Title:
Effects of Jiedu Huoxue decoction on the expression of FGF23 and Klotho in the kidneys of rats with chronic kidney disease
作者:
周 鹏1; 孙妲男2; 李 勇2; 徐 丽2; 乔 伟1
(1.黑龙江中医药大学研究生院,黑龙江 哈尔滨 150040; 2.黑龙江中医药大学附属第二医院肾内科,黑龙江 哈尔滨 150001)
Author(s):
ZHOU Peng; SUN Danan; LI Yong; XU Li; QIAO Wei
(Graduate School of Heilongjiang University of Chinese Medicine,Harbin 150040,China)
关键词:
慢性肾脏病;  解毒活血汤;  去菀陈莝;  成纤维细胞生长因子23;  Klotho蛋白;  大鼠
Keywords:
Chronic kidney disease;  Jiedu Huoxue decoction;  Quwan Chencuo;  FGF23;  Klotho;  Rats
分类号:
R 692
DOI:
DOI:10.3969/j.issn.1000-7369.2024.01.003
文献标志码:
A
摘要:
目的:观察解毒活血汤对慢性肾脏病(CKD)大鼠肾脏FGF23、Klotho的影响。方法:将60只SPF级健康雄性SD大鼠,随机分空白组、模型组、中药高剂量组、中药中剂量组、中药低剂量组,每组12只。采用腺嘌呤加高磷饮食制作CKD大鼠伴血管钙化模型。采用生化试剂盒测定血清中肌酐、尿素氮、钙、磷水平; Western blot法检测肾脏组织中FGF23、Klotho的表达。结果:与空白组相比,其余各组血清中肌酐、尿素氮、钙、磷均有明显变化(P<0.05或P<0.01); 和模型组相比,中药高剂量组、中药中剂量组、中药低剂量组CKD大鼠血清中肌酐、尿素氮、磷水平明显改善(P<0.05),FGF23、Klotho蛋白表达量增高(P<0.05),血清钙水平升高(P<0.05)。结论:解毒活血汤可以改善CKD 大鼠肾脏功能,可以通过提高CKD大鼠肾脏组织中FGF23、Klotho蛋白的表达影响失衡的FGF23-Klotho轴,进而调节CKD大鼠血中钙、磷浓度。
Abstract:
Objective:To observe the effects of Jiedu Huoxue decoction on FGF23 and Klotho in rats with chronic kidney disease(CKD).Methods:Sixty healthy male SD rats with SPF grade were randomly divided into black group A,group B,group I,group H,and group G,with 12 rats in each group.A model of vascular calcification in rats with CKD was prepared using adenine plus high-phosphorus diet.Biochemical kits were used to determine Scr,BUN,Ca,P levels.The Western blot method detected the expression of FGF23,Klotho in kidney tissue.Results:Compared with the blank group,the serum serum Scr,BUN,Ca and P were significantly changed in the rest groups(P<0.05 or P<0.01).In compared to the model group,the serum levels of Scr,BUN and P in group G,group H and group I were significantly improved(P<0.05),the expression of FGF23 and Klotho proteins was increased(P<0.05),and the serum Ca level was increased(P<0.05).Conclusion:Jiedu Huoxue decoction can improve the kidney function of CKD rats,and can affect the unbalanced FGF23-Klotho axis by increasing the expression of FGF23 and Klotho proteins in the kidney tissues of CKD rats,and then regulate the concentration of Ca and P in the blood of CKD rats.

参考文献/References:

[1] KATHARINA B S V S,GIOVANNI G.CKD prevalence varies across the European general population[J].Journal of the American Society of Nephrology:JASN,2016,27(7):2135-2147.
[2] 于小勇,曾晓荣,程小红,等.维持性血液透析钙磷代谢紊乱与踝肱指数相关性研究[J].陕西医学杂志,2014,43(12):1654-1655.
[3] Kidney Disease:Improving Global Outcomes(KDIGO)CKD-MBD Update Work Group.KDIGO 2017 clinical practice guideline update for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD)[J].Kidney International Supplements,2017,7(3):1-59.
[4] 王慧敏,魏玮.成纤维细胞生长因子23与慢性肾脏病关系研究进展[J].陕西医学杂志,2016,45(7):930-932.
[5] 富丽,刘胜阳,张宝桐,等.慢性肾脏病矿物质和骨异常患者血清白细胞介素-18、分泌型Klotho 和骨保护素的表达及意义[J].陕西医学杂志,2019,48(8):1035-1037,1051.
[6] 于梅,于卓.张琪用加味解毒活血汤治疗慢性肾衰基础上的急性肾衰竭经验[J].中国中医基础医学杂志,2011,17(6):695-696.
[7] 杨波,乔延恒,赵岩茹,等.从十年文献分析探寻中医药诊治慢性肾衰竭病因病机[J].辽宁中医杂志,2016,43(1):58-59.
[8] 刘晓静,孟令栋,黄萍,等.慢性肾衰竭的中医研究进展[J].实用临床医药杂志,2019,23(1):129-132.
[9] 杨俊,赵春芝,张磊,等.桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭血瘀水湿证的临床研究[J].北京中医药,2022,41(11):1305-1309.
[10] 范丽妃,吴竞,陈扬荣.陈扬荣运用虫类药从“络”论治慢性肾衰竭[J].中国中医基础医学杂志,2022,28(5):698-700.
[11] 李英南.去菀陈莝在慢性肾炎治疗中的应用[J].辽宁中医药大学学报,2008,10(5):9-10.
[12] 郭俊,高庆和,邓楹君,等.基于“去宛陈莝”分期论治慢性前列腺炎体会[J].环球中医药,2021,14(8):1497-1499.
[13] 王文蔚,贾成祥,王用书.论“新病入络”与“久病入络”[J].中华中医药杂志,2018,33(3):1030-1033.
[14] 何春苗,张春戬.解毒活血汤临床研究进展[J].实用中医药杂志,2022,38(10):1824-1826.
[15] 张天锡,史磊,刘雯,等.连翘化学成分、药理活性现代研究[J].辽宁中医药大学学报,2016,18(12):222-224.
[16] 林飞武,王自善,戎珍,等.柴胡的药理作用、化学成分及开发利用研究[J].亚太传统医药,2020,16(10):202-205.
[17] 梁瀞云,唐燕,司马玲,等.柴胡疏肝散在肝脏疾病中的应用研究进展[J].陕西中医,2022,43(11):1651-1653.
[18] 马艳春,吴文轩,胡建辉,等.当归的化学成分及药理作用研究进展[J].中医药学报,2022,50(1):111-114.
[19] 吴玲芳,王子墨,赫柯芊,等.赤芍的化学成分和药理作用研究概况[J].中国实验方剂学杂志,2021,27(18):198-206.
[20] 苏殷婷,陈兆善,赖志昆.活血化瘀药在冠脉微血管功能障碍治疗中的运用规律[J].陕西中医,2023,44(7):961-964.
[21] 王慧,钟国跃,张寿文,等.枳壳化学成分、药理作用的研究进展及其质量标志物的预测分析[J].中华中医药学刊,2022,40(9):184-192,284.
[22] 王波,王丽,刘晓峰,等.中药甘草成分和药理作用及其现代临床应用的研究进展[J].中国医药,2022,17(2):316-320.
[23] 王佐梅,肖洪彬,李雪莹,等.中药红花的药理作用及临床应用研究进展[J].中华中医药杂志,2021,36(11):6608-6611.
[24] 黄芳,王洁.Klotho-FGF23轴在慢性肾脏病中的研究进展[J].右江医学,2021,49(8):625-628.
[25] 马春园,郝丽荣.FGF23-Klotho轴在慢性肾脏病骨矿物质代谢紊乱中的作用[J].医学综述,2015,21(7):1169-1172.
[26] OLENA A,JESSICA B,CHRISTIANE S,et al.Klotho lacks an FGF23-Independent role in mineral homeostasis[J].Journal of Bone and Mineral Research:The Official Journal of the American Society for Bone and Mineral Research,2017,32(10):2049-2061.

相似文献/References:

[1]屈 凯,王悦彤,王漱非,等.基于文献研究探讨益肾散结法防治肾小球硬化的理论内涵*[J].陕西中医,2019,(7):919.
　QU Kai,WANG Yuetong,WANG Shufei,et al.Based on literature research to explore the theoretical connotation of Kidney-reinforcing and Mass-disintegrating for prevention and treatment of glomerulosclerosis[J].,2019,(1):919.
[2]任永朋,华 琼,刘彦妍,等.中医“治未病”思想在防治肾脏病中的应用*[J].陕西中医,2019,(8):1101.
　REN Yongpeng,HUA Qiong,LIU Yanyan,et al.The application of the thought of “preventive treatment of disease” in the prevention and treatment of kidney disease in traditional Chinese medicine[J].,2019,(1):1101.
[3]张宏强,李桂霞,章彩凤,等.许筠治疗慢性肾病临床药对举隅*[J].陕西中医,2020,(6):808.[doi:DOI:10.3969/j.issn.10007369.2020.06.031]
[4]陈紫薇,陈 明△.从脾论治慢性肾脏病的生物学基础探讨*[J].陕西中医,2020,(11):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
　CHEN Ziwei,CHEN Ming..Discuss the biological foundation for chronic disease therapy from treatment through the spleen[J].,2020,(1):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
[5]董 怡,马 静,余楠楠,等.大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响[J].陕西中医,2021,(7):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
　DONG Yi,MA Jing,YU Nannan,et al.Effect analysis of rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life[J].,2021,(1):910.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
[6]齐 宁,宋姝西,刘香玉,等.参芪延肾方治疗慢性肾脏病疗效及对患者半乳糖缺陷IgA1、晚期糖基化终产物和微炎性反应状态的影响[J].陕西中医,2022,(5):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
　QI Ning,SONG Shuxi,LIU Xiangyu,et al.Effects of Shenqi Yanshen recipe on the levels of Gd-IgA1,AGEs and micro inflammatory response in patients with chronic kidney disease[J].,2022,(1):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
[7]麦芳雄,张香兰,朱德礼.温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病疗效及对患者血清转化生长因子β1、纤维连接蛋白水平的影响[J].陕西中医,2022,(8):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
　MAI Fangxiong,ZHANG Xianglan,ZHU Deli.Clinical efficacy of Wenshen Jianpi Qinghua decoction in the treatment of chronic kidney disease with spleen-kidney qi deficiency and its effect on serum transforming growth factor β1 and fibronectin levels[J].,2022,(1):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
[8]杨淑彬,李 婷,李晓妮,等.不同中药结肠透析模式对慢性肾脏病患者胃肠道症状和营养状态的影响[J].陕西中医,2022,(12):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
　YANG Shubin,LI Ting,LI Xiaoni,et al.Effects of different colon dialysis modes of traditional Chinese medicine on gastrointestinal symptoms and nutritional status in patients with chronic kidney disease[J].,2022,(1):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
[9]陈 曦,董凯旋,周 荣,等.中药调控p38丝裂原活化蛋白激酶/核因子κB通路治疗肾纤维化研究进展[J].陕西中医,2023,(7):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
　CHEN Xi,DONG Kaixuan,ZHOU Rong,et al.Research progress of traditional Chinese medicine regulating p38MAPK/NF-κB pathway in treatment of renal fibrosis[J].,2023,(1):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
[10]周 林,禹 红,刘毓玲,等.活肾通络方联合依那普利对慢性肾脏病患者纤维化标志物、人附睾蛋白4水平的影响[J].陕西中医,2023,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
　ZHOU Lin,YU Hong,LIU Yuling,et al.Effect of Huoshen Tongluo decoction and enalapril on renal function,fibrosis markers and HE4 levels in patients with chronic renal disease[J].,2023,(1):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
[11]杨 灡,孙妲男,李 勇,等.解毒活血汤对慢性肾脏病大鼠肾脏Smad2、Smad3表达的影响[J].陕西中医,2025,46(1):19.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.004]
　YANG Lan,SUN Danan,LI Yong,et al.Effects of Jiedu Huoxue decoction on CKD rat kidney Smad2,Smad3[J].,2025,46(1):19.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.004]

备注/Memo

备注/Memo:
基金项目:黑龙江省自然科学基金资助项目(LH2021H086); 黑龙江省中医药科研项目(ZHY2020-139,ZHY2022-176); 黑龙江省博士后研究人员落户黑龙江科研启动金资助项目(LBH-Q21190)
更新日期/Last Update: 2024-01-09